• Recorded Webinar
  • On-Demand
  • Pediatrics
This webinar will present the newest content of the 2024 Pediatric Obesity Algorithm®.
  • 1.00 AMA PRA Category 1 Credit
  • Non-CME
  • Recorded Webinar
  • On-Demand
  • Non-CME/Sponsored
  • Pharmacotherapy
Akkermansia muciniphila, a key player in the gut microbiome, has emerged as a significant influencer of GLP-1, a hormone with profound implications for metabolic health.
  • Recorded Webinar
  • On-Demand
  • Nutrition Therapy
Nutrition is one of the pillars of obesity treatment. While clinicians are easily able to advise patients what NOT to eat, telling patients what to eat can be harder.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Pediatrics
  • Special Populations
Youth with special healthcare needs are at increased risk for obesity and associated co-morbidities.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Pediatrics
In this webinar, we will focus on deepening attendees understanding of the pathophysiology, diagnosis, and treatment of various comorbidities associated with childhood obesity. Dr.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Join us for an in-depth webinar designed for clinicians and scientists, exploring the intricate relationship between the gut microbiome and obesity.
  • 0.75 AMA PRA Category 1 Credit
  • Non-CME
  • Non-CME/Sponsored
  • Pharmacotherapy
Many factors influence a patient's weight loss journey including metabolism, genetics, lifestyle, and other biological and cultural differences.
  • Recorded Webinar
  • On-Demand
  • Treatment Strategies
As psychedelics become increasingly decriminalized in various cities and countries, and excitement builds among scientists, physicians, and the general public, it is likely that more individuals wi
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Pharmacotherapy
Join us for an informative session designed to enhance your expertise in prescribing GLP1 medications for the treatment of obesity.
  • 0.50 AMA PRA Category 1 Credit

Pages